Clinical trial
A Pilot Study of Recombinant Human Bone Morphogenetic Protein-2 and Biphasic Calcium Phosphate With or Without the TSRH® Spinal System for Posterolateral Lumbar Fusion in Patients With Symptomatic Degenerative Disc Disease
NCT01494441 is registered in ClinicalTrials.gov with Medtronic Spinal and Biologics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study of Recombinant Human Bone Morphogenetic Protein-2 and Biphasic Calcium Phosphate With or Without the TSRH® Spinal System for Posterolateral Lumbar Fusion in Patients With Symptomatic Degenerative Disc Disease
- Lead sponsor
- Medtronic Spinal and Biologics
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 31, 1999
- Completion date
- March 31, 2003
- Enrollment
- 27 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
degenerative disc disease